2019 International Congress

Wednesday, September 25, 2019

1:15pm-2:45pm

Co-administration of levodopa and zonisamide reduces the serotonin transporter expression in a rat model of Parkinson’s disease

R. Tohge, S. Kaneko, S. Morise, M. Oki, M. Nakamura, N. Takenouchi, H. Kusaka (Hirakata, Japan)

Physiology and Pathophysiology  ·  Les Muses, Level 3

1:15pm-2:45pm

Cognitive ability characterization of rat model with mutated alpha-synuclein overexpression

C. Laloux, C. Lachaud, K. Timmerman, E. Bezard, R. Bordet, D. Devos (Lille, France)

Cognition and Cognitive Disorders  ·  Agora 3 East, Level 3

1:15pm-2:45pm

Cognitive and psychiatric course in the initial lustrum of Parkinson disease: the glass is half full

D. Weintraub, C. Caspell-Garcia, H. Cho, T. Simuni, A. Siderowf, C. Coffey, D. Aarsland, R. Alcalay, L. Chahine, J. Eberling, A. Espay, J. Hamilton, J. Leverenz, I. Litvan, I. Richard, L. Rosenthal, M. York (Philadelphia, PA, USA)

Non-Motor Symptoms  ·  Agora 3 West, Level 3

1:15pm-2:45pm

Cognitive changes after deep brain stimulation of the subthalamic nucleus in Parkinson’s disease: A longitudinal study.

J. Mana, F. Růžička, A. Fečíková, E. Růžička, D. Urgošík, R. Jech, O. Bezdicek (Prague, Czech Republic)

Non-Motor Symptoms  ·  Agora 3 West, Level 3

1:15pm-2:45pm

Cognitive complaint in Parkinson’s disease patients with normal cognition: Canary in the coal mine?

R. Purri, L. Brennan, J. Rick, S. Xie, B. Deck, L. Chahine, N. Dahodwala, A. Chen-Plotkin, J. Duda, J. Morley, R. Akhtar, J. Trojanowski, D. Weintraub (Philadelphia, PA, USA)

Cognition and Cognitive Disorders  ·  Agora 3 East, Level 3

1:15pm-2:45pm

Cognitive impairment in Parkinson’s Disease: A cross-sectional association study

A. Simon, C. Rodriguez-Blazquez, MJ. Forjaz, P. Martinez-Martin (Madrid, Spain)

Cognition and Cognitive Disorders  ·  Agora 3 East, Level 3

1:15pm-2:45pm

Cognitive impairment in patients with Parkinson’s Disease

E. Kolupaeva, I. Zhukova, N. Zhukova, M. Nikitina, O. Izhboldina, I. Mironova, Z. Kislukhina (Tomsk, Russian Federation)

Non-Motor Symptoms  ·  Agora 3 West, Level 3

1:15pm-2:45pm

Cognitive impairment profile of patients with Essential Tremor and Parkinson’s Disease

A. Abundes-Corona, A. Cervantes-Arriaga, R. Zerón-Martínez, R. Solís-Vivanco, O. Cárdenas-Saenz, M. Rodríguez-Violante (Mexico City, Mexico)

Cognition and Cognitive Disorders  ·  Agora 3 East, Level 3

1:15pm-2:45pm

Cognitive Inhibitory Control and Response to Dopaminergic Medication in Parkinson’s Disease

M. El Haddouchi, A. Handberg, K. Svaerke, A. Loekkegaard (Copenhagen, Denmark)

Non-Motor Symptoms  ·  Agora 3 West, Level 3

1:15pm-2:45pm

Cognitive multi-domain assessment in Parkinson’s disease: A more sensitive approach

C. Trujillo, S. Baez, E. Herrera, A. Garcia, A. Ibañez, J. Cardona (Santiago de Cali, Colombia)

Cognition and Cognitive Disorders  ·  Agora 3 East, Level 3